1. |
Toosy AT, Mason DF, Miller DH. Optic neuritis[J]. Lancet Neurol, 2014, 13(1): 83-99. DOI: 10.1016/S1474-4422(13)70259-X.
|
2. |
Kitley J, Leite MI, Nakashima I, et al. Prognostic factors and disease course in aquaporin- 4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan[J]. Brain, 2012, 135(Pt 6): 1834-1849. DOI: 10.1093/brain/aws109.
|
3. |
Jarius S, Paul F, Weinshenker BG, et al. Neuromyelitis optica[J]. Nat Rev Dis Primers, 2020, 6(1): 85. DOI: 10.1038/s41572-020-0214-9.
|
4. |
Jasiak-Zatonska M, Kalinowska-Lyszczarz A, Michalak S, et al. The immunology of neuromyelitis optica-current knowledge, clinical implications, controversies and future perspectives[J]. Int J Mol Sci, 2016, 17(3): 273. DOI: 10.3390/ijms17030273.
|
5. |
Kitley J, Waters P, Woodhall M, et al. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study[J]. JAMA Neurol, 2014, 71(3): 276-283. DOI: 10.1001/jamaneurol.2013.5857.
|
6. |
Spadaro M, Gerdes LA, Mayer MC, et al. Histopathology and clinical course of MOG-antibody-associated encephalomyelitis[J]. Ann Clin Transl Neurol, 2015, 2(3): 295-301. DOI: 10.1002/acn3.164.
|
7. |
Mitsdoerffer M, Kuchroo V, Korn T. Immunology of neuromyelitis optica: a T cell-B cell collaboration[J]. Ann N Y Acad Sci, 2013, 1283: 57-66. DOI: 10.1111/nyas.12118.
|
8. |
Brummelman J, Pilipow K, Lugli E. The single-cell phenotypic identity of human CD8+ and CD4+ T cells[J]. Int Rev Cell Mol Biol, 2018, 341: 63-124. DOI: 10.1016/bs.ircmb.2018.05.007.
|
9. |
Taves MD, Ashwell JD. Glucocorticoids in T cell development, differentiation and function[J]. Nat Rev Immunol, 2021, 21(4): 233-243. DOI: 10.1038/s41577-020-00464-0.
|
10. |
中华医学会眼科学分会神经眼科学组. 视神经炎诊断和治疗专家共识(2014年)[J]. 中华眼科杂志, 2014, 50(6): 459-463. DOI: 10.3760/cma.j.issn.0412-4081.2014.06.013.Neuro-ophthalmology Group, Ophthalmological Branch, Chinese Medical Association. Expert consensus on diagnosis and treatment of optic neuritis (2014)[J]. Chin J Ophthalmol, 2014, 50(6): 459-463. DOI: 10.3760/cma.j.issn.0412-4081.2014.06.013.
|
11. |
中华医学会眼科学分会神经眼科学组. 中国脱髓鞘性视神经炎诊断和治疗循证指南(2021年)[J]. 中华眼科杂志, 2021, 57(3): 171-186. DOI: 10.3760/cma.j.cn112142-20201124-00769.Neuro-ophthalmology Group, Ophthalmology Branch, Chinese Medical Association. Evidence-based guidelines for diagnosis and treatment of demyelinating optic neuritis in China (2021)[J]. Chin J Ophthalmol, 2021, 57(3): 171-186. DOI: 10.3760/cma.j.cn112142-20201124-00769.
|
12. |
Sparrow JM, Taylor H, Qureshi K, et al. The cataract national dataset electronic multi-centre audit of 55, 567 operations: risk indicators for monocular visual acuity outcomes[J]. Eye (Lond), 2012, 26: 821-826. DOI: 10.1038/eye.2012.51.
|
13. |
Strachan MW, Reynolds RM, Frier BM, et al. The relationship between type 2 diabetes and dementia[J]. Br Med Bull, 2008, 88(1): 131-146. DOI: 10.1093/bmb/ldn042.
|
14. |
Wang KC, Tsai CP, Lee CL, et al. Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis optica[J]. Neuroscience, 2012, 226: 510-516. DOI: 10.1016/j.neuroscience.2012.08.041.
|
15. |
Kalluri SR, Rothhammer V, Staszewski O, et al. Functional characterization of aquaporin-4 specific T cells: towards a model for neuromyelitis optica[J/OL]. PLoS One, 2011, 6(1): e16083 [2011-01-14]. https://pubmed.ncbi.nlm.nih.gov/21264240/. DOI: 10.1371/journal.pone.0016083.
|
16. |
Röcken M, Racke M, Shevach EM. IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease[J]. Immunol Today, 1996, 17(5): 225-231. DOI: 10.1016/0167-5699(96)80556-1.
|
17. |
Tran GT, Hodgkinson SJ, Carter NM, et al. IL-5 promotes induction of antigen- specific CD4+CD25+ T regulatory cells that suppress autoimmunity[J]. Blood, 2012, 119(19): 4441-4450. DOI: 10.1182/blood-2011-12-396101.
|
18. |
Vocca L, Di Sano C, Uasuf CG, et al. IL-33/ST2 axis controls Th2/IL-31 and Th17 immune response in allergic airway diseases[J]. Immunobiology, 2015, 220(8): 954-963. DOI: 10.1016/j.imbio.2015.02.005.
|
19. |
Zhang Y, Yao XY, Gao MC, et al. Th2 axis-related cytokines in patients with neuromyelitis optica spectrum disorders[J]. CNS Neurosci Ther, 2018, 24(1): 64-69. DOI: 10.1111/cns.12774.
|
20. |
Chihara N, Aranami T, Sato W, et al. Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica[J]. Proc Natl Acad Sci USA, 2011, 108(9): 3701-3706. DOI: 10.1073/pnas.1017385108.
|
21. |
Kong BS, Kim Y, Kim GY, et al. Increased frequency of IL-6-producing nonclassical monocytes in neuromyelitis optica spectrum disorder[J]. J Neuroinflammation, 2017, 14(1): 191. DOI: 10.1186/s12974-017-0961-z.
|
22. |
Wei Y, Chang H, Li X, et al. Cytokines and tissue damage biomarkers in first-onset neuromyelitis optica spectrum disorders: significance of interleukin-6[J]. Neuroimmunomodulation, 2018, 25(4): 215-224. DOI: 10.1159/000494976.
|
23. |
Knier B, Rothhammer V, Heink S, et al. Neutralizing IL-17 protects the optic nerve from autoimmune pathology and prevents retinal nerve fiber layer atrophy during experimental autoimmune encephalomyelitis[J]. J Autoimmun, 2015, 56: 34-44. DOI: 10.1016/j.jaut.2014.09.003.
|
24. |
Kurebayashi Y, Nagai S, Ikejiri A, et al. Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells[J]. Genes Cells, 2013, 18(4): 247-265. DOI: 10.1111/gtc.12039.
|
25. |
Hou MM, Li YF, He LL, et al. Proportions of Th17 cells and Th17-related cytokines in neuromyelitis optica spectrum disorders patients: a meta-analysis[J/OL]. Int Immunopharmacol, 2019, 75: 105793[2019-08-08]. https://pubmed.ncbi.nlm.nih.gov/31401379/. DOI: 10.1016/j.intimp.2019.105793.
|
26. |
Kang H, Li H, Ai N, et al. Markedly elevated serum level of T-helper cell 17-related cytokines/chemokines in acute myelin oligodendrocyte glycoprotein antibody-associated optic neuritis[J/OL]. Front Neurol, 2020, 11: 589288[2020-11-13]. https://pubmed.ncbi.nlm.nih.gov/33281728/. DOI: 10.3389/fneur.2020.589288.
|
27. |
Banuelos J, Lu NZ. A gradient of glucocorticoid sensitivity among helper T cell cytokines[J]. Cytokine Growth Factor Rev, 2016, 31: 27-35. DOI: 10.1016/j.cytogfr.2016.05.002.
|
28. |
Kemanetzoglou E, Andreadou E. CNS Demyelination with TNF-α blockers[J]. Curr Neurol Neurosci Rep, 2017, 17(4): 36. DOI: 10.1007/s11910-017-0742-1.
|
29. |
Li YJ, Zhang F, Qi Y, et al. Association of circulating follicular helper T cells with disease course of NMO spectrum disorders[J]. J Neuroimmunol, 2015, 278: 239-246. DOI: 10.1016/j.jneuroim.2014.11.011.
|
30. |
Pentón-Rol G, Cervantes-Llanos M, Martínez-Sánchez G, et al. TNF-alpha and IL-10 downregulation and marked oxidative stress in neuromyelitis optica[J]. J Inflamm (Lond), 2009, 6: 18. DOI: 10.1186/1476-9255-6-18.
|
31. |
Saadoun S, Waters P, MacDonald C, et al. Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain[J]. Ann Neurol, 2012, 71(3): 323-333. DOI: 10.1002/ana.22686.
|